Vascular Solutions
AI-enabled platform for vascular assessment
Company profile
Company profile
Circle Cardiovascular Imaging (Circle CVI) is a Canadian-based medical imaging software company founded in 2007 that has become a globally recognized leader in cardiovascular imaging analysis. The company develops innovative AI-powered software solutions designed to enhance cardiovascular imaging analysis and improve patient care across cardiac and neurological applications. Circle's flagship platform, cvi42, provides comprehensive tools for cardiac MR, cardiac CT, vascular CT, interventional planning, and electrophysiology, serving as an all-encompassing cardiac imaging solution. The platform features automated workflows powered by AI trained on large datasets and various pathological patterns, enabling accurate diagnosis, improved patient throughput, and enhanced reproducibility. In 2024, Circle launched its next generation of products centered on accessibility, interoperability, and efficiency. The company also offers StrokeSENS, an AI-based solution for early identification of acute stroke that aids front-line physicians in timely patient management decisions. With over 600 installations worldwide across more than 100 countries, Circle serves leading healthcare institutions globally, including top hospitals that rely on its technology for both clinical and research purposes. The company maintains strong partnerships with major medical imaging OEMs including GE Healthcare and Siemens Healthineers, offering integrated deployment options on their workstation platforms. Circle's solutions seamlessly integrate with existing clinical workflows and systems, featuring streamlined reporting capabilities that reduce clerical workload and improve patient outcomes. The company has earned industry-leading customer satisfaction scores and maintains a reputation for exceptional customer service and continuous innovation in the cardiovascular imaging field.
Company description Circle Cardiovascular Imaging official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: GE FastStroke, GE Healthcare AW Server, GE Healthcare AW workstation, Siemens Healthineers syngo.via.
Company milestones
2024 marked the launch of next generation of products centered around accessibility, interoperability, and efficiency. cvi42 version 6.4 released.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-enabled platform for vascular assessment
One Platform for All Your Advanced Cardiac Imaging Needs
Dedicated tools for comprehensive assessment of coronary artery disease
Market-leading solution for all clinical and research cardiac MR needs
Pre-procedural planning tools for electrophysiologists
Fast and effective planning for structural heart interventions
Streamlined reporting system for cardiovascular imaging
AI-based identification of acute stroke pathology for faster clinical decisions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
AJNR. American journal of neuroradiology · Jun 29, 2026
Reference ranges for myocardial native T1, T2, and extracellular volume at 5.0T cardiac magnetic resonance imaging in healthy adults.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · Jun 4, 2026
Prognosis and risk stratification in first-presentation myocardial infarction with nonobstructive coronary arteries using stress cardiac MRI.Insights into imaging · May 29, 2026
Comparing prognostic significance of dual bolus and dual sequence quantitative stress perfusion cardiac magnetic resonance.European heart journal. Cardiovascular Imaging · Feb 27, 2026
Late gadolinium enhancement in patients with and without autoimmune rheumatic diseases: "walking, we create the way".European journal of radiology · Feb 1, 2026
Lateralized cerebral arterial blood flow and blood pressure adaptations to short-term head-down tilt: a 4D flow MRI study with cognitive function assessment.Military Medical Research · Jan 1, 2026
Clinical validation
NCT03648385 · Mentioned · COMPLETED
Prognostic Role of LA Strain in Acute Myocardial InfarctionNCT06408636 · Mentioned · COMPLETED
Regulatory
K251027 · 510k · Oct 27, 2025
StrokeSENS ASPECTS Software ApplicationK250221 · 510k · Jul 1, 2025
cvi42 Software ApplicationK242781 · 510k · Oct 15, 2024
Cardiac CT Function Software ApplicationK241038 · 510k · Jun 7, 2024
Myocardial Strain Software ApplicationK232661 · 510k · Dec 7, 2023
TruPlan Computed Tomography (CT) Imaging SoftwareK222593 · 510k · Jan 18, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Automated workflows and streamlined reporting
AI-based imaging technology
Automated workflows increase time for patient care
Net Promoter Score (NPS) and Customer Satisfaction (CSAT)
High-volume CMR service delivery with over 12 consultants and multiple trainees
Would not be able to deliver high-volume CMR service without cvi42 and report42, used clinically for approximately 4 years after 10 years of research use
CMR imaging for clinical and research purposes since 2008, shaping workflow practices
Software maintained core simplicity while delivering technological advancements over a decade, enabling productive workflow
Clinical practice for cardiac MRI and CT post-processing analysis with improved communication of findings
Described as invaluable to clinical practice with intuitive analysis for both clinical and research purposes
High-volume tertiary cardiac center delivering high-quality imaging reports with seamless post-processing across scanning platforms, supporting clinical service, CMR training, and research studies
Enables delivery of high-volume CMR service with reasonable turn-around time across multiple consultants and trainees
Routine clinical studies and advanced research with multi-vendor capabilities, pathology tagging for education and multi-centric study review
Faster read time per patient with comprehensive tools for simple and complex studies, recognized as reference for CMR imaging
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Circle Cardiovascular Imaging's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.